Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine
Rats were treated continuously for 12 months with therapeutically equivalent doses of either haloperidol (1.4-1.6 mg/kg/day), sulpiride (102-109 mg/kg/day), or clozapine (24-27 mg/kg/day). After treatment for 3 and 12 months with haloperidol or clozapine but not sulpiride, striatal acetylcholine levels were increased. Striatal choline acetyltransferase activity was not altered by any drug treatment. V(max) for striatal acetylcholinesterase activity during the course of 12 months' treatment with haloperidol or clozapine, but not with sulpiride, tended to increase; K(m) was not altered by any drug treatment. B(max) for specific striatal [3H]quinuclidinyl benzilate binding was not altered by haloperidol or sulpiride treatment but was transiently elevated after 6 months of clozapine treatment, thereafter returning to control levels. K(d) was not altered by any drug treatment. These findings indicate that alterations in striatal acetylcholine content caused by chronic treatment with some but not all neuroleptics are due to changes in cholinergic neuronal activity rather than neurotransmitter synthesis or destruction. The effects of haloperidol but not those of clozapine may be related to the emergence of functional striatal dopamine receptor supersensitivity. Since haloperidol (which is associated with a high prevalence of tardive dyskinesias) but not clozapine (which is not) had similar effects on striatal cholinergic function, the latter may not be related to the emergency of tardive dyskinesias during chronic therapy.
282-292
Rupniak, N. M.J.
043ae8d6-a074-46a7-a8d1-2fef1749b647
Briggs, R. S.
a6b65ef0-e90c-4c07-bf5b-b70130c128b3
Petersen, M. M.
43045e58-dcf0-4245-a69e-c039f18b8f6e
Mann, S.
feac17d6-0a57-4673-a406-f8dbcaee54e7
Reavill, C.
8c5c0602-3c28-4a2b-af80-f6ec52040f04
Jenner, P.
785c25df-ec64-4181-b057-26dd31cd9d84
Marsden, C. D.
ccd1ecc8-3eb4-4699-a87e-0bfba0dd40b0
1986
Rupniak, N. M.J.
043ae8d6-a074-46a7-a8d1-2fef1749b647
Briggs, R. S.
a6b65ef0-e90c-4c07-bf5b-b70130c128b3
Petersen, M. M.
43045e58-dcf0-4245-a69e-c039f18b8f6e
Mann, S.
feac17d6-0a57-4673-a406-f8dbcaee54e7
Reavill, C.
8c5c0602-3c28-4a2b-af80-f6ec52040f04
Jenner, P.
785c25df-ec64-4181-b057-26dd31cd9d84
Marsden, C. D.
ccd1ecc8-3eb4-4699-a87e-0bfba0dd40b0
Rupniak, N. M.J., Briggs, R. S., Petersen, M. M., Mann, S., Reavill, C., Jenner, P. and Marsden, C. D.
(1986)
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.
Clinical Neuropharmacology, 9 (3), .
(doi:10.1097/00002826-198606000-00006).
Abstract
Rats were treated continuously for 12 months with therapeutically equivalent doses of either haloperidol (1.4-1.6 mg/kg/day), sulpiride (102-109 mg/kg/day), or clozapine (24-27 mg/kg/day). After treatment for 3 and 12 months with haloperidol or clozapine but not sulpiride, striatal acetylcholine levels were increased. Striatal choline acetyltransferase activity was not altered by any drug treatment. V(max) for striatal acetylcholinesterase activity during the course of 12 months' treatment with haloperidol or clozapine, but not with sulpiride, tended to increase; K(m) was not altered by any drug treatment. B(max) for specific striatal [3H]quinuclidinyl benzilate binding was not altered by haloperidol or sulpiride treatment but was transiently elevated after 6 months of clozapine treatment, thereafter returning to control levels. K(d) was not altered by any drug treatment. These findings indicate that alterations in striatal acetylcholine content caused by chronic treatment with some but not all neuroleptics are due to changes in cholinergic neuronal activity rather than neurotransmitter synthesis or destruction. The effects of haloperidol but not those of clozapine may be related to the emergence of functional striatal dopamine receptor supersensitivity. Since haloperidol (which is associated with a high prevalence of tardive dyskinesias) but not clozapine (which is not) had similar effects on striatal cholinergic function, the latter may not be related to the emergency of tardive dyskinesias during chronic therapy.
This record has no associated files available for download.
More information
Published date: 1986
Identifiers
Local EPrints ID: 479116
URI: http://eprints.soton.ac.uk/id/eprint/479116
ISSN: 0362-5664
PURE UUID: 89a185bb-6f33-4a04-89b8-31644e0ee349
Catalogue record
Date deposited: 20 Jul 2023 16:36
Last modified: 17 Mar 2024 03:36
Export record
Altmetrics
Contributors
Author:
N. M.J. Rupniak
Author:
R. S. Briggs
Author:
M. M. Petersen
Author:
S. Mann
Author:
C. Reavill
Author:
P. Jenner
Author:
C. D. Marsden
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics